Virus-like Particles: Properties and Characteristics of Reference Materials

Virus-like particles (VLPs) have long attracted the attention of biologists and metrologists due to their dual nature. Despite their similarity to viruses, VLPs lack a virus DNA or RNA, thereby posing no threat of infection. The development of methods for the creation and standardization of VLPs, as well as for monitoring their characteristics, represents an important problem in the field of biotechnology and molecular biology. In this work, we aim to substantiate the requirements, methods, and instruments used to ensure the traceability of VLP-based certified reference materials (CRMs). The following methods for characterization of biological and physicochemical properties of such CRMs were considered: mass balance; high-performance liquid chromatography-mass spectrometry (HPLC–MS); gas chromatography-mass spectrometry (GC–MS); Karl Fischer coulometric titration; ion chromatography; inductively coupled plasma mass spectrometry; and isotope dilution. It was established that VLP-based CRMs should meet the following requirements: the presence of molecular patterns common to many pathogenic biological agents (PBAs) but absent in the organism; traceability to SI units (Systeme international d’unites, SI); the absence of own genetic material; the presence only of inactivated homogenous strains when used for vaccine delivery. VLP-based CRMs facilitate metrological support in the field of medicine and vaccine production.

1. Burns J. R., Lamarre B., Pyne A. L. B., Noble J. E., Ryadnov M. G. DNA origami inside-out viruses. ACS Synthetic Biology. 2018;7(3):767–773. https://doi.org/10.1021/acssynbio.7b00278

2. Bárcena J., Blanco E. Design of novel vaccines based on virus-like particles or chimeric virions. In: Mateu M. (eds). Structure and Physics of Viruses. Subcellular Biochemistry. 2013;68:631–665. https://doi.org/10.1007/978-94-007-6552-8_21

3. Matsumura E. E., Guo F., Boogers D., Oevelen D. V., Vu S. T., Falk B. W. Citrus sudden death-associated virus as a new expression vector for rapid in planta production of heterologous proteins, chimeric virions, and virus-like particles. Biotechnology Reports. 2022;35: e00739. https://doi.org/10.1016/j.btre.2022.e00739

4. Castelletto V., de Santis E., Alkassem H., Lamarre B., Noble J. E., Ray S. Structurally plastic peptide capsules for synthetic antimicrobial viruses. Chemical Science. 2016;7:1707–1711. https://doi.org/10.1039/c5sc03260a

5. Syomin B. V., Ilyin Y. V. Virus-like particles as an instrument of vaccine production. Molekulyarnaya Biologiya. 2019;53(3):367–379. https://doi.org/10.1134/S0026898419030157

6. Jané-Valbuena J., Nibert M. L., Spencer S. M., Walker S. B., Baker T. S., Chen Ya. et al. Reovirus virion-like particles obtained by recoating infectious subvirion particles with baculovirus-expressed sigma3 protein: an approach for analyzing sigma3 functions during virus entry. Journal of Virology. 1999;73(4):2963–2973. https://doi.org/10.1128/JVI.73.4.2963–2973.1999

7. Zepp F. Principles of vaccine design-lessons from nature. Vaccine. 2010;28(Suppl 3):14 –24. https://doi.org/10.1016/j.vaccine.2010.07.020

8. Flint S. J., Enquist L. W., Racaniello V. R., Skalka A. M. Virus offence meets host defense. In: Principles of virology: molecular biology, pathogenesis, and control of animal viruses, 2nd edn. ASM Press, Washington. 2003. P. 531–584.

9. Kalman L. V., Datta V., Williams M., Zook J. M., Salit M. L., Han J. Y. Development and characterization of reference materials for genetic testing: focus on public partnerships. Annals of Laboratory Medicine. 2016;36(6):513–520. https://doi.org/10.3343/alm.2016.36.6.513

10. Briones A., Martos G., Bedu M., Choteau T., Josephs R. D., Wielgosz R. I., Ryadnov M. G. An SI-traceable reference material for virus-like particles. iScience. 2022;25(5):104294. https://doi.org/10.1016/j.isci.2022.104294

11. Directive 2001/83/EC of the European Parliament and of the Council on the Community code relating to medicinal products for human use as regards advanced therapy medicinal products. Available via: https://www.ejprarediseases.org/wp-content/uploads/2021/10/DIRECTIVE-2009–120-EC.pdf. Accessed 10 August 2022.

12. Kulyabina E. V., Kulyabina T. V. Use of state standard specimens and test mixtures for verification and calibration of measurement provisions used in biological research. Measurement Techniques. 2013;56:1429–1431. https://doi.org/10.1007/s11018-014-0395-2

13. Kulyabina E. V. To the relationship between the possibility of surviving of human being as a biological species and the level of metrological support for laboratory medicine and bioassay. Zakonodatel’naja i prikladnaja metrologija. 2017;6(151):49–51. (In Russ.).